WSM | 2026-04-29 Pre-Q1-FY26 update (next ER: May 6, 2026). Q4 FY25 already reviewed April 6. This refresh integrates new data: transcript now available, Liberty Mutual white-label deal (April 23), three carrier partnerships in Q1 2026, stock +66% from lows, fresh analyst initiations. Prior file:
analyses/LIFE/LIFE_earnings-review_Q4_FY25.md
Thesis is strengthening — and three weeks ahead of Q1 results, this is no longer just a "broken insurtech mispricing" story. Liberty Mutual white-labeling Ethos' underwriting engine (April 23) reframes the company from "DTC insurtech with concentration risk" to "life insurance infrastructure platform powering Top-5 P&C carriers." Combined with the now-available transcript (high-quality CEO/CFO answers, 7 analyst firms covering, articulate moat), three carrier partnerships in Q1 2026, and management explicitly telegraphing a ~10pp drop in carrier concentration in the upcoming 10-K, the single biggest existential risk in my April 6 thesis is being actively de-risked.
The stock has rallied 66% from $10.35 lows to $17.17, taking market cap back over $1B. Valuation is no longer "absurdly cheap" — but at 2.1x EV/run-rate revenue, 11x run-rate P/E, PEG of 0.17x for a 65% YoY grower with 23% EBITDA margins and a brand-new $1B+ partnership, it's still inexpensive by any growth-investor standard. Nuf said.
→ I'm sizing now, not waiting for May 6. Initiate 3% starter position pre-print. Add to 5-7% on a Q1 beat-and-raise. Run for the hills if Q1 misses guidance OR third-party channel posts a second sequential decline.
| Item | April 6 Status | April 29 Update | Impact on Thesis |
|---|---|---|---|
| Earnings transcript | Unavailable (flagged red flag) | Full transcript with 7 analyst Q&A | Strengthens — high-quality, articulate CEO answers |
| Liberty Mutual partnership | Did not exist | Announced April 23 — full white-label, top-5 P&C carrier | Strengthens (material) — reframes platform thesis |
| Carrier concentration | 88–98% from 3 carriers | CEO telegraphed -10pp decline in 10-K | Strengthens — risk being actively addressed |
| Stock price | $11.89 (-37% from IPO) | $17.17 (+66% from lows, -10% from IPO) | Valuation tighter but still attractive |
| Analyst coverage | Limited | 9 analysts: Goldman ($31 PT), William Blair, BofA, etc. | Strengthens — institutional conviction crystallising |
| Three Q1 partnerships | Not visible | NA IUL (Jan), Banner final-expense (Mar), Liberty Mutual (Apr) | Strengthens — carrier-platform velocity confirmed |
| Lockup expiry July 28 | Active overhang | ~12 weeks away | Still a near-term risk |
| Third-party channel | -5.5% QoQ in Q4 | No new data until May 6 | Pending |
Eish!! This is the most important development. I underweighted platform optionality in the April 6 analysis because I had no concrete proof of B2B traction. Now I do.
What's actually happening: Liberty Mutual — a top-5 US P&C insurer with massive consumer brand recognition — is using Ethos' underwriting engine to power its own digitally-issued life insurance product, sold under the Liberty Mutual brand through Liberty Mutual's distribution channels. Ethos provides instant decisioning, no-exam underwriting, the data infrastructure. Liberty Mutual provides reach.
This is the Bestow pivot — but Ethos retains its DTC business, its agent channel, AND now adds B2B infrastructure. Three revenue rails, not one.
Why it matters for thesis:
Risk to flag: Need to understand the economics. White-label deals can be high-volume / low-margin (Ethos becomes infrastructure) or high-take-rate (Ethos retains commission economics). Will press on this in the May 6 call. For now I'm assuming neutral-to-positive contribution margin given Ethos' 98% gross margins leave room.
The April 6 analysis flagged "no transcript" as a material data gap. Now the full Q&A is available with 7 analyst firms (Goldman, Barclays, Baird, Citi, Deutsche Bank, BofA, JPMorgan). This is unusually deep institutional coverage for a sub-$1B IPO.
What I learned that changes my view:
| Topic | What CEO/CFO Said | WSM Read |
|---|---|---|
| 93% direct channel growth | "Vertically integrated stack seeing gains up and down the cycle. Marketing models, UX, underwriting all improving simultaneously" | Bullish. No single dependency = durable. ML/data flywheel real. |
| AI competitive moat | "Not just access to AI tools — it's native platform, years of structured underwriting data, real-time feedback loops" | Bullish. This is the right answer. Tools are commoditised; data is not. |
| Marketing scalability | "Majority of S&M in upper-funnel (TV, social, radio) — users NOT seeking life insurance. More scalable at right unit economics" | Bullish. Push model works at scale, unlike Google-search arbitrage |
| Test velocity | "3-week experiments in 2023 now take 3 days. 6x improvement" | Bullish. Tangible engineering productivity metric |
| Unit economics | "Cash profitability by month 2 across all channels and products" | Bullish. Specific, quantified, disciplined |
| Carrier concentration | "10-K will show concentration decline by ~10pp within existing 6 partners" | Bullish. Specific commitment, near-term test |
| Q1 vs FY guide spread | "Strong operational momentum into 2026. January policy activations strong; February pacing ahead of targets" | Bullish (loaded statement). CFO essentially pre-confirming Q1 beat |
| New product cadence | "3-4 per year. Wait-and-see; ascribe very little revenue to new products" | Bullish (conservative). Classic management underpromise. |
| NPS >70 | First disclosed in Q4 — vs industry 14 | Bullish. Differentiated customer experience is real |
Tone assessment: Confident, data-driven, no defensive language, no evasions. Management articulates 3-year strategy with specifics. CFO's "February pacing ahead of targets" is the kind of forward color first-time public CFOs don't say without confidence.
Compare to my April 6 framework: I had management quality at "Adequate" because I was inferring from Glassdoor and pre-IPO press. With the transcript, I'm upgrading to "Good" — not yet "Exceptional" because they have one quarter of public track record. May 6 is the test.
| | Q424 | Q125 | Q225 | Q325 | Q425 | | | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | |---|---|---|---|---|---| | Revenue ($M) | 66.5 | 88.9 | 93.8 | 94.9 | **110.1** | | QoQ % | — | +33.6% | +5.6% | +1.2% | **+16.0%** | | YoY % | +66% | +58% | +34% | +53% | **+65.5%** | | Gross Margin [GAAP] | 97.7% | ~98% | ~98% | ~98% | **98.1%** | | Adj EBITDA ($M) | 14.7 | 19.0 | 21.0 | 24.0 | 25.8 | | EBITDA Margin | 22.1% | 21.3% | 22.3% | 25.3% | 23.5% | | Policies Activated | 38,515 | 46,283 | 49,219 | 48,122 | 54,714 | | ARPU ()|1, 727|1, 920|1, 906|1, 972|* * 2, 012 * *||DirectRev(M) | 38.0 | 50.0 | 56.0 | 62.0 | 74.2 | | 3P Rev ($M) | 28.0 | 33.0 | 38.0 | 38.0 | 35.9 | | Contribution Margin | 39.1% | 41.6% | 40.4% | 42.1% | 42.9% |
Same headline: All-time highs across the board in Q4. YoY accelerated from 34% trough to 65.5% peak. Direct nearly doubled YoY. Third-party first sequential decline (-5.5% QoQ) — still the one yellow flag.
| Metric | April 6 (@ $11.89) | April 29 (@ $17.17) | Change |
|---|---|---|---|
| Market cap | $748M | $1.08B | +44% |
| Cash & investments | ~$326M (post-IPO) | $157M (Q4 reported)* | — |
| Enterprise Value | ~$430M | ~$925M | +115% |
| EV / Run-rate Revenue | ~1.0x | ~2.1x | +110% |
| EV / FY26 guided ($512M) | 0.84x | 1.81x | +115% |
| P/S (run-rate) | 1.7x | 2.45x | +44% |
| P/E (run-rate, GAAP) | 7.6x | 11.0x | +44% |
| PEG (P/E / YoY growth) | 0.13x | 0.17x | Still <0.5 (very attractive) |
| EV/Adj EBITDA (FY25) | 4.8x | 10.4x | More than doubled |
| Rule of 40 | 88 (Q4) | 88 (unchanged) | Top decile |
*Note: Brief shows $157M cash & investments at Dec 31 2025 — this excludes the post-IPO proceeds (~$200M raised Jan 2026). Adjusted cash is more like $325–350M, lowering EV closer to $725–750M and EV/run-rate to ~1.7x. The brief's $746M EV figure (1.7x) is the right ballpark. I'll use ~1.7-2.1x as the working range.
The "unmissably cheap" trade is gone. At $11.89 a 65% grower with 98% GM at 1.0x EV/run-rate revenue was a once-a-decade dislocation. It got bought.
At $17.17, it's still cheap by growth-investor standards but not absurdly so:
For comparison: AXON trades at ~25x EV/Rev and ~70x P/E with similar growth (35%) and lower margins. AppLovin trades at 15x. PLTR trades at 35x. LIFE at 1.7x EV/Rev for similar Rule of 40 is still mispriced by 3-5x even on a discount-for-execution-risk basis.
The thesis at $17 isn't "valuation arbitrage on technicals." It's "durable growth compounder at a fintech multiple." I'll take that.
| Risk | April 6 Severity | April 29 Severity | Why Changed |
|---|---|---|---|
| Carrier concentration | Existential | High but mitigating | CEO telegraphed -10pp in 10-K; Liberty Mutual + Banner + NA IUL add diversification |
| Lockup expiry (Jul 28, 2026) | High | High | ~12 weeks away. SoftBank still ~10% underwater at $17.17 vs $2.7B 2021 valuation. Stock has actually closed some of the gap, which counterintuitively could reduce forced-selling intensity |
| FY26 guide deceleration | Medium | Low-Medium | CFO said February pacing ahead of targets. Likely conservative guide. |
| Third-party channel decline | Medium | Medium | No update until May 6. Still the one yellow flag. |
| No transcript / mgmt unproven | Medium | Low | Resolved. Strong Q&A performance from CEO/CFO. |
| Glassdoor culture flags | Low-Medium | Low-Medium | Stable. Not deteriorating. 4.3/5 with 205 reviews. |
| Insurtech stigma | Medium | Low | Liberty Mutual deal materially shifts narrative. Goldman, William Blair, BofA all bullish. |
Net effect: Risk-adjusted thesis is materially stronger than April 6. The single existential risk (carrier concentration) is being actively de-risked by management with a specific 10-K commitment and three carrier partnerships in 90 days. The "no transcript" data gap closed favorably.
| Test | Pass | Fail |
|---|---|---|
| Q1 revenue | ≥ $146M (top of guide) | < $144M (miss) |
| Q1 EBITDA | ≥ $32M (top of guide) | < $30M |
| Third-party revenue | ≥ $36M sequential (recovers) | < $34M (second decline) |
| FY26 guide | Maintained or raised | Lowered |
| Carrier concentration disclosure (10-K) | -10pp confirmed | Smaller-than-promised |
| New carrier signings | 1+ announced or hinted | None |
| Liberty Mutual economics | Color on take rate / contribution | Vague / dodge |
| Direct channel YoY | ≥ +80% | < +60% |
Sizing logic:
Prior Beliefs (April 6):
Updated Beliefs (April 29):
Ethos is the digital infrastructure of US life insurance distribution. It earns 98% gross margin commission revenue from a three-sided platform (consumers + agents + carriers), now with a fourth surface (white-label B2B carrier infrastructure via Liberty Mutual). The market has stopped pricing it as a broken insurtech and started pricing it as a durable growth compounder, but it still trades at a fintech multiple for a Rule-of-40-of-88 platform. Carrier concentration was the existential risk; management is actively retiring it with three new partnerships in 90 days and a -10pp commitment in the upcoming 10-K. Lockup expiry July 28 is the residual technical risk, but SoftBank's underwater position has mostly closed.
Thesis status: Strengthening → upgrading to Strong (would be Conviction-Tier if not for residual lockup overhang and 1-quarter public track record).
Initiate 3% starter position today (April 29) ahead of May 6 earnings.
The math: at 3%, if it doubles I make 3% portfolio gain; if it halves I lose 1.5%. The risk-reward is asymmetric and the catalyst is 7 days away. Run-rate P/E of 11x for a 65% YoY grower with active carrier diversification and a brand-new top-5 P&C platform deal is the kind of setup I don't pass on at a 3% starter.
-wsm
(Initiating LIFE 3%, pre-Q1 FY26 print)
Sources: Q4 FY25 transcript (now available), Q4 FY25 press release (EDGAR 8-K), Q4 2025 investor presentation, Liberty Mutual partnership PR (April 23, 2026), Banner Life PR (March 24, 2026), North American IUL PR (January 7, 2026), Goldman Sachs initiation note (Feb 26, 2026), William Blair initiation note (Feb 23, 2026), Trustpilot, Glassdoor, Simply Wall St, scuttlebutt 2026-04-29.